
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
Intelligent Bio Solutions today announced the closing of its previously announced underwritten public offering of units for gross proceeds of













